Miki T - Search Results

1

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.

Takata R, Katagiri T, Kanehira M, Tsunoda T, Shuin T, Miki T, Namiki M, Kohri K, Matsushita Y, Fujioka T, Nakamura Y. Takata R, et al. Among authors: miki t. Clin Cancer Res. 2005 Apr 1;11(7):2625-36. doi: 10.1158/1078-0432.CCR-04-1988. Clin Cancer Res. 2005. PMID: 15814643 Clinical Trial.

2

Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors.

Miki T, Mizutani Y, Nonomura N, Nomoto T, Nakao M, Saiki S, Kotake T, Okuyama A. Miki T, et al. Cancer. 2002 Nov 1;95(9):1879-85. doi: 10.1002/cncr.10918. Cancer. 2002. PMID: 12404281 Free article.

3

Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.

Nakanishi H, Mizutani Y, Kawauchi A, Ukimura O, Shiraishi T, Hatano M, Mizuno M, Yoshida J, Miki T. Nakanishi H, et al. Among authors: miki t. Clin Cancer Res. 2003 Mar;9(3):1129-35. Clin Cancer Res. 2003. PMID: 12631618

4

Analysis of gene-expression profiles in testicular seminomas using a genome-wide cDNA microarray.

Okada K, Katagiri T, Tsunoda T, Mizutani Y, Suzuki Y, Kamada M, Fujioka T, Shuin T, Miki T, Nakamura Y. Okada K, et al. Among authors: miki t. Int J Oncol. 2003 Dec;23(6):1615-35. Int J Oncol. 2003. PMID: 14612934

5

Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs.

Ashida S, Nakagawa H, Katagiri T, Furihata M, Iiizumi M, Anazawa Y, Tsunoda T, Takata R, Kasahara K, Miki T, Fujioka T, Shuin T, Nakamura Y. Ashida S, et al. Among authors: miki t. Cancer Res. 2004 Sep 1;64(17):5963-72. doi: 10.1158/0008-5472.CAN-04-0020. Cancer Res. 2004. PMID: 15342375

6

Oncogenic role of NALP7 in testicular seminomas.

Okada K, Hirota E, Mizutani Y, Fujioka T, Shuin T, Miki T, Nakamura Y, Katagiri T. Okada K, et al. Among authors: miki t. Cancer Sci. 2004 Dec;95(12):949-54. doi: 10.1111/j.1349-7006.2004.tb03182.x. Cancer Sci. 2004. PMID: 15596043 Free PMC article.

7

[The second-line chemotherapy for urological cancers].

Miki T, Mikami K, Mizutani Y. Miki T, et al. Gan To Kagaku Ryoho. 2005 Jan;32(1):33-8. Gan To Kagaku Ryoho. 2005. PMID: 15675579 Review. Japanese.

8

Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.

Ashida S, Furihata M, Katagiri T, Tamura K, Anazawa Y, Yoshioka H, Miki T, Fujioka T, Shuin T, Nakamura Y, Nakagawa H. Ashida S, et al. Among authors: miki t. Clin Cancer Res. 2006 May 1;12(9):2767-73. doi: 10.1158/1078-0432.CCR-05-1995. Clin Cancer Res. 2006. PMID: 16675569

9

Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.

Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T. Hirota E, et al. Among authors: miki t. Int J Oncol. 2006 Oct;29(4):799-827. Int J Oncol. 2006. PMID: 16964377

10

Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy.

Takata R, Katagiri T, Kanehira M, Shuin T, Miki T, Namiki M, Kohri K, Tsunoda T, Fujioka T, Nakamura Y. Takata R, et al. Among authors: miki t. Cancer Sci. 2007 Jan;98(1):113-7. doi: 10.1111/j.1349-7006.2006.00366.x. Cancer Sci. 2007. PMID: 17116130 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,906 results

Search Page

Filters